LEO Pharma receives Health Canada approval for atopic dermat

LEO Pharma has received approval from Health Canada for Adtralza (tralokinumab) to treat moderate-to-severe atopic dermatitis (AD).

Related Keywords

Canada , Canadian , Amanda Cresswell Melville , Jill Archibald , Eczema Society Canada , Society Canada ,